Detalhe da pesquisa
1.
Enhanced tumor control activities of anti-mPD-L1 antibody and antigen-presenting cell-like natural killer cell in an allograft model.
BMC Cancer
; 24(1): 136, 2024 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38279092
2.
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial.
Gastric Cancer
; 27(2): 375-386, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38281295
3.
Multicenter evaluation of the safety and efficacy of selective internal radiation therapy with yttrium-90 resin microspheres in Taiwan: data from the RESIN registry.
J Gastroenterol Hepatol
; 2024 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38615197
4.
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma.
Oncology (Williston Park)
; 37(4): 176-183, 2023 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37104758
5.
Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062.
Jpn J Clin Oncol
; 53(3): 221-229, 2023 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36533429
6.
The outcomes and prognostic factors of patients with hepatocellular carcinoma and normal serum alpha fetoprotein levels.
J Formos Med Assoc
; 122(7): 593-602, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36456455
7.
Preclinical and Clinical Observations Implying Combination Therapy to Enhance the Efficacy of the Her-2/neu B-Cell Peptide-Based Vaccine HER-Vaxx and to Prevent Immune Evasion.
Int J Mol Sci
; 25(1)2023 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38203458
8.
Synergistic effect of Abraxane that combines human IL15 fused with an albumin-binding domain on murine models of pancreatic ductal adenocarcinoma.
J Cell Mol Med
; 26(7): 1955-1968, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35174623
9.
Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience.
Invest New Drugs
; 40(4): 789-797, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35477812
10.
Anti-PD-1 combined sorafenib versus anti-PD-1 alone in the treatment of advanced hepatocellular cell carcinoma: a propensity score-matching study.
BMC Cancer
; 22(1): 55, 2022 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35016637
11.
The combination of gene hyperamplification and PD-L1 expression as a biomarker for the clinical benefit of tislelizumab in gastric/gastroesophageal junction adenocarcinoma.
Gastric Cancer
; 25(5): 943-955, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35778636
12.
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study.
Gastric Cancer
; 25(1): 207-217, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34480657
13.
Bevacizumab and atezolizumab as first-line therapy for advanced hepatocellular carcinoma: A Taiwanese subgroup analysis on efficacy and safety.
J Formos Med Assoc
; 121(12): 2430-2437, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36153210
14.
Efficacy and Renal Safety of Prophylactic Tenofovir Alafenamide for HBV-Infected Cancer Patients Undergoing Chemotherapy.
Int J Mol Sci
; 23(19)2022 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36232631
15.
Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE-240.
Cancer
; 127(6): 865-874, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33231873
16.
The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon.
Br J Cancer
; 125(6): 816-825, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34188197
17.
Affibody-conjugated 5-fluorouracil prodrug system preferentially targets and inhibits HER2-expressing cancer cells.
Biochem Biophys Res Commun
; 582: 137-143, 2021 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34710829
18.
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab.
Gastric Cancer
; 24(4): 946-958, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33743112
19.
Prediction of survival according to kinetic changes of cytokines and hepatitis status following radioembolization with yttrium-90 microspheres.
J Formos Med Assoc
; 120(4): 1127-1136, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32978044
20.
The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma.
J Formos Med Assoc
; 120(8): 1581-1590, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33334658